Krüger-Genge, A.; Köhler, S.; Laube, M.; Haileka, V.; Lemm, S.; Majchrzak, K.; Kammerer, S.; Schulz, C.; Storsberg, J.; Pietzsch, J.;
et al. Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis. Cells 2023, 12, 1965.
https://doi.org/10.3390/cells12151965
AMA Style
Krüger-Genge A, Köhler S, Laube M, Haileka V, Lemm S, Majchrzak K, Kammerer S, Schulz C, Storsberg J, Pietzsch J,
et al. Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis. Cells. 2023; 12(15):1965.
https://doi.org/10.3390/cells12151965
Chicago/Turabian Style
Krüger-Genge, Anne, Susanne Köhler, Markus Laube, Vanessa Haileka, Sandy Lemm, Karolina Majchrzak, Sarah Kammerer, Christian Schulz, Joachim Storsberg, Jens Pietzsch,
and et al. 2023. "Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis" Cells 12, no. 15: 1965.
https://doi.org/10.3390/cells12151965
APA Style
Krüger-Genge, A., Köhler, S., Laube, M., Haileka, V., Lemm, S., Majchrzak, K., Kammerer, S., Schulz, C., Storsberg, J., Pietzsch, J., Küpper, J.-H., & Jung, F.
(2023). Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis. Cells, 12(15), 1965.
https://doi.org/10.3390/cells12151965